Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
ZacksRegeneron (REGN) and Sage Therapeutics (SAGE) are in focus on regulatory and pipeline updates.
Regeneron (REGN) and Sage Therapeutics (SAGE) are in focus on regulatory and pipeline updates.